BiomEdit Receives Environment Clearance for BE-101
Slice of Agriculture Team
11/14/2025
Key highlights
- FONSI letter received from USDA for BE-101
- First non-antibiotic biologic for necrotic enteritis
- Field safety trials to start in early Q1 2026
Source: PR Newswire
Notable Quote
“ The FONSI letter represents another key regulatory milestone as we work to deliver a first-of-its-kind solution for poultry producers. ”
Aaron Schacht, CEO at BiomEdit
Why this matters
This announcement signifies a major step forward in the development of non-antibiotic solutions for poultry health, addressing a critical need in the industry while advancing BiomEdit's commercialization plans. This development is particularly significant for the agriculture sector.
